HB Fuller Co (NYSE:FUL) – Research analysts at Gabelli issued their FY2021 earnings per share estimates for shares of HB Fuller in a report issued on Friday. Gabelli analyst R. Morbelli forecasts that the specialty chemicals company will earn $4.95 per share for the year.
A number of other equities research analysts also recently weighed in on the company. Zacks Investment Research downgraded HB Fuller from a “buy” rating to a “hold” rating in a report on Monday, December 11th. ValuEngine downgraded HB Fuller from a “buy” rating to a “hold” rating in a report on Friday, November 10th. Citigroup downgraded HB Fuller from a “buy” rating to a “neutral” rating and set a $60.00 price objective for the company. in a report on Tuesday, October 31st. Deutsche Bank upgraded HB Fuller from a “hold” rating to a “buy” rating and boosted their price objective for the company from $60.00 to $62.00 in a report on Thursday, January 25th. Finally, Seaport Global Securities upgraded HB Fuller from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $63.00 to $66.00 in a report on Thursday, January 25th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and three have issued a buy rating to the company. The company has an average rating of “Hold” and an average target price of $61.80.
Shares of HB Fuller (FUL) opened at $49.73 on Monday. The firm has a market capitalization of $2,507.66, a P/E ratio of 44.01 and a beta of 1.57. The company has a quick ratio of 1.56, a current ratio of 2.27 and a debt-to-equity ratio of 2.30. HB Fuller has a 1-year low of $48.20 and a 1-year high of $58.74.
HB Fuller (NYSE:FUL) last issued its earnings results on Tuesday, January 23rd. The specialty chemicals company reported $0.75 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.84 by ($0.09). The business had revenue of $678.20 million during the quarter, compared to the consensus estimate of $613.58 million. HB Fuller had a return on equity of 12.83% and a net margin of 2.53%.
The business also recently announced a quarterly dividend, which will be paid on Thursday, February 15th. Investors of record on Thursday, February 1st will be given a dividend of $0.15 per share. The ex-dividend date of this dividend is Wednesday, January 31st. This represents a $0.60 annualized dividend and a dividend yield of 1.21%. HB Fuller’s payout ratio is 53.10%.
In related news, VP Timothy J. Keenan sold 6,500 shares of HB Fuller stock in a transaction that occurred on Wednesday, November 8th. The stock was sold at an average price of $55.08, for a total transaction of $358,020.00. Following the transaction, the vice president now owns 29,611 shares of the company’s stock, valued at $1,630,973.88. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.10% of the stock is owned by insiders.
Hedge funds have recently bought and sold shares of the business. Russell Investments Group Ltd. boosted its position in HB Fuller by 97.4% in the third quarter. Russell Investments Group Ltd. now owns 16,446 shares of the specialty chemicals company’s stock worth $955,000 after purchasing an additional 8,116 shares during the last quarter. Highbridge Capital Management LLC purchased a new position in HB Fuller in the third quarter worth $712,000. BNP Paribas Arbitrage SA lifted its position in shares of HB Fuller by 51.1% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 26,699 shares of the specialty chemicals company’s stock valued at $1,550,000 after buying an additional 9,026 shares during the last quarter. Trexquant Investment LP purchased a new position in shares of HB Fuller during the 3rd quarter valued at $253,000. Finally, Vanguard Group Inc. lifted its position in shares of HB Fuller by 1.0% during the 2nd quarter. Vanguard Group Inc. now owns 5,108,535 shares of the specialty chemicals company’s stock valued at $261,098,000 after buying an additional 53,030 shares during the last quarter. 92.89% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: “Research Analysts Issue Forecasts for HB Fuller Co’s FY2021 Earnings (FUL)” was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece on another site, it was illegally copied and republished in violation of United States and international copyright & trademark law. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/05/research-analysts-issue-forecasts-for-hb-fuller-cos-fy2021-earnings-ful.html.
About HB Fuller
H.B. Fuller Company is a formulator, manufacturer and marketer of adhesives, sealants and other specialty chemical products. The Company’s segments include Americas Adhesives, Europe, India, Middle East and Africa (EIMEA), Asia Pacific, Construction Products and Engineering Adhesives. The Americas Adhesives, EIMEA and Asia Pacific operating segments produce and supply industrial adhesives products for applications in various markets, including durable assembly, nonwoven and hygiene, and textile.
Receive News & Ratings for HB Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HB Fuller and related companies with MarketBeat.com's FREE daily email newsletter.